This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Another important reason to outsource sales with a CSO is that it allows pharma companies to adjust the number of med-reps or pharmacy sales reps based on the duration of the contract as agreed between the two companies. It is estimated that from 2010 and on contract sales services have grown by 37,5%.
In fact, the pharmaceutical industry’s development pipeline has reached an all-time high of 20,109 products under active development at the end of January 2022, an increase of 500 from 2021. 1 And, on average , the FDA approved 60% more drugs between 2010-2019 than the yearly average over the previous decade.
Important elements within this expectation are the build up of strong contributions from Rotarix, Cervarix and Tykerb, while the outlook for GSK’s important asthma franchise becomes less clear beyond 2010. PT: Glaxo shares have fallen 17% in the past year.
I remember back in my pharmaceuticalsales rep days and I’m talking as far as 2009 or 2010. We’re in 2022 so a lot has happened since 2010. Have a conversation with us about our program, the Medical Sales Career Builder. How long have you been working in the opioid addiction space?
I wanted to go into pharmaceuticalsales. For those of you reading, you can Google that in 2009 and 2010, the pharmaceuticalsales industry died. The honest truth is when I was in college, I double majored, one in Business and Marketing and the other major is Biochemistry. I graduated college in 2009.
We organize all of the trending information in your field so you don't have to. Join 8,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content